Teratogenicity of psychotherapeutic medications.
D000014:Abnormalities, Drug-Induced / Q000209:etiology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001522:Behavior, Animal / Q000187:drug effects; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008094:Lithium / Q000009:adverse effects; D008431:Maternal-Fetal Exchange; D010640:Phenothiazines; D011247:Pregnancy; D011619:Psychotropic Drugs / Q000009:adverse effects*
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D010640:Phenothiazines; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D008094:Lithium